Remicade Dosage

Your healthcare provider prescribes a unique Remicade dosage depending on a number of factors that include your age and body weight, the medical condition being treated, other underlying medical conditions, and medications currently taken.

Below is the usual dosage of Remicade (Infliximab). However, it is possible for you to get a totally different dosage. Do not adjust your dose without consulting your healthcare provider.

Management of Symptoms of Ulcerative Colitis, Plaque Psoriasis, and Psoriatic Arthritis

For adults, as well as for children older than 6 years being treated for ulcerative colitis, the recommended dose of Remicade is 5 mg/kg administered through the intravenous route (injected into a vein). After the initial dose, the succeeding two doses should be administered after two and six weeks, consecutively.

The maintenance dose should be given every eight weeks thereafter.

Management of Symptoms of Ankylosing Spondylitis

The recommended dose for patients with ankylosing spondylitis is 5 mg/kg administered through the intravenous route (injected into a vein). After the initial dose, the succeeding two doses should be given after two and six weeks, consecutively.

The maintenance dose should be given every six weeks thereafter.

Management of Symptoms of Crohn’s Disease

For adults and children, the recommended dosage of Remicade is 5 mg/kg administered through the intravenous route (injected into a vein). After the initial dose, the next two doses should be administered after two and six weeks, consecutively. The maintenance dose should be taken every eight weeks thereafter. If the regular dose seems to be less effective in patients who have previously responded well to it, the dosage may be increased to 10 mg/kg every eight weeks. However, in patients with severe heart failure, the maintenance dose should not exceed 5 mg/kg.

Management of Symptoms of Crohn’s Disease

When used for patients with Crohn’s Disease, the recommended dose of Remicade is 3 mg/kg administered through the intravenous route (injected into a vein). After the initial dose, the two succeeding doses should be taken two and six weeks, subsequently. The maintenance dose should be given eight weeks, thereafter. Depending on the patient’s response to treatment, the dose may be increased to 10 mg/kg every eight weeks. However, in patients with severe heart failure, the maintenance dose should not exceed 5 mg/kg.

Remicade is intended to be used along with methotrexate when used for treating rheumatoid arthritis. Methotrexate can be taken either orally or intravenously.

General Information on Remicade Dosage

• Remicade (Infliximab) is available only as dry powder for intravenous injection.
• Depending on the severity of the condition being treated and the patient’s response to treatment, Remicade may be given more frequently during the initial phase of therapy, then the maintenance dose may be given every six or eight weeks.
• If you do not understand the dosing schedule or are unsure about anything related to Remicade, consult your healthcare provider or pharmacist. Do not discontinue taking this medication unless specifically instructed by your healthcare provider.